Rouses Point Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ROUSES POINT PHARMS, and what generic and branded alternatives to ROUSES POINT PHARMS drugs are available?
ROUSES POINT PHARMS has one approved drug.
Summary for Rouses Point Pharms
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Rouses Point Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rouses Point Pharms | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 202524-001 | Aug 27, 2012 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Rouses Point Pharms | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 202524-002 | Aug 27, 2012 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
